Skip to content
Saturday 15 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
+0.53%
CAC 40
8,636.80
-0.16%
STOXX 50
6,539.59
-0.09%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Friday 16 April 2021 4:42 pm

One in six UK adults fully vaccinated against coronavirus

By: Poppy Wood

Add as a preferred source on Google
Covid-19 Vaccinations At Salisbury Cathedral

One in six adults in the UK are now fully vaccinated against Covid-19, with more than 2m second doses delivered in the past seven days, latest official figures show.

More than 8.9m people have now received both doses of a Covid vaccine — equivalent to around 17 per cent of Britain’s adult population. A further 23.6m people have been given their first injection.

The government will prioritise providing second jabs to people who have already received a first dose over the next few months, after delivery issues promised to disrupt vaccine supplies in the coming weeks.

Second doses of coronavirus vaccines must follow within 12 weeks of the first, meaning millions of people who received their initial jab in January and February have recently had a follow-up dose or are due to receive a second jab over the next few weeks.

Over-45s were invited to book their Covid jabs earlier this week after the government reached its target of offering a first dose to the nine most vulnerable groups, including everybody over the age of 50.

Ministers had promised to offer a first jab to to all over-50s, the clinically vulnerable and health and social care workers by 15 April.

Prime Minister Boris Johnson hailed “another hugely significant milestone” in the UK’s vaccine rollout, adding that he was confident the government will meet its target to offer a first dose to all adults in Britain by 31 July.

Read more

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

Men, the severely overweight, high-risk workers and ethnic minorities will also be targeted in the next phase of the vaccine rollout, the Joint Committee on Vaccination and Immunisation (JCVI) said earlier this week.

The JCVI said the NHS should proactively encourage take-up of the jab in these groups due to their heightened risk from Covid.

The government last month launched a new publicity campaign to boost vaccine uptake amongst minority groups, after figures released by the Office for National Statistics (ONS) revealed that people of black African origin are five and a half times more likely not to have received a first injection compared to white British.

Meanwhile, the Department of Health and Social Care (DHSC) announced on Wednesday it will launch a five-week consultation on plans to make vaccines compulsory for care home staff amid concerns that low uptake could put residents at risk.

Experts on the Scientific Advisory Group for Emergencies (Sage) said at least 80 per cent of staff and 90 per cent of residents in elderly care homes must be vaccinated to provide a minimum level of protection against outbreaks.

Currently, only 53 per cent of older adult care homes in England have achieved this threshold. DHSC warned the figure could leave up to 150,000 residents in care homes at increased risk of catching coronavirus.

Read more

Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Re-lockdown
  • Vaccine

Trending Articles

  • Revolut takes flight with launch of new airport lounges

  • Grandparents fund university degrees to avoid inheritance tax net

  • Revolut chatbot goes rogue by charging users to cancel subscription

  • Brompton Bicycle sues former adviser for ‘professional negligence’

  • As It Happened: Stocks dip as oil’s ‘slowing demand’ in focus; Iran threatens to extend war

More from Morning Wire

  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software – An Objective EEG/ERP Brain Health Assessment

    Business Wire
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Screens aren’t the problem, it’s what’s on them that’s rotting our brains

    Opinion
    Unfortunately, without additional context from the article or details about what the image depicts, it is challenging to g...
  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook